SLNO stock news
This page provides real-time market news, earnings updates, and company announcements related to Soleno Therapeutics, Inc. (SLNO).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-15 12:41 EST
Soleno Therapeutics (SLNO) Sparks Confidence Amid Topline Outperformance
Finviz2026-02-16 17:24:49
Rhythm Pharmaceuticals Is Well-Positioned, Analyst Says Could Capture Big Share Of Rare Obesity Market
Finviz2026-02-19 17:45:57
Biopharmaceutical company Soleno Therapeutics recently announced a major personnel appointment
老虎证券2026-02-26 11:29:00
Wells Fargo Cuts PT on Soleno Therapeutics (SLNO) to $110 From $114 - Here's Why
Finviz2026-03-01 09:30:13
Soleno Therapeutics, Inc. (SLNO) Revenue Tops Expectations With $91.7M in Q4 Results, TD Cowen Maintains Buy
Finviz2026-03-04 07:33:08
Soleno Therapeutics, Inc. (SLNO) Revenue Tops Expectations With $91.7M in Q4 Results, TD Cowen Maintains Buy
Finviz2026-03-04 07:33:08
H.C. Wainwright Lowers PT on Soleno (SLNO), Keeps a Buy Rating
Finviz2026-03-10 00:36:10
Reports indicate that Neurocrine Biosciences is about to acquire Soleno Therapeutics at a price of approximately $2.5 billions, prompting Soleno Therapeutics' shares to surge 30% in pre-market trading.
老虎证券2026-04-06 09:03:42
Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio
Finviz2026-04-06 11:03:56
According to the latest disclosed agreement terms, if the acquisition is terminated under specific circumstances, Soleno Therapeutics (SLNO) will be required to pay Neurocrine Biosciences (NBIX) a termination fee of up to 953 millions dollars.
老虎证券2026-04-06 12:08:02
US Stocks Movement | Soleno surges over 33% after being acquired by Neurocrine for $2.9 billions
格隆汇2026-04-06 13:39:11
Piper Sandler has announced a downgrade of Soleno Therapeutics' stock rating from "Overweight" to "Neutral".
老虎证券2026-04-07 12:33:37
Soleno Therapeutics, Inc. (SLNO) Revenue Tops Expectations With $91.7M in Q4 Results, TD Cowen Maintains Buy
Finviz2026-03-04 07:33:08
Soleno Therapeutics, Inc. (SLNO) Revenue Tops Expectations With $91.7M in Q4 Results, TD Cowen Maintains Buy
Finviz2026-03-04 07:33:08
H.C. Wainwright Lowers PT on Soleno (SLNO), Keeps a Buy Rating
Finviz2026-03-10 00:36:10
Reports indicate that Neurocrine Biosciences is about to acquire Soleno Therapeutics at a price of approximately $2.5 billions, prompting Soleno Therapeutics' shares to surge 30% in pre-market trading.
老虎证券2026-04-06 09:03:42
Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio
Finviz2026-04-06 11:03:56
According to the latest disclosed agreement terms, if the acquisition is terminated under specific circumstances, Soleno Therapeutics (SLNO) will be required to pay Neurocrine Biosciences (NBIX) a termination fee of up to 953 millions dollars.
老虎证券2026-04-06 12:08:02
US Stocks Movement | Soleno surges over 33% after being acquired by Neurocrine for $2.9 billions
格隆汇2026-04-06 13:39:11
Piper Sandler has announced a downgrade of Soleno Therapeutics' stock rating from "Overweight" to "Neutral".
老虎证券2026-04-07 12:33:37
SLNO stock chart
SLNO stock detailsSLNO stock price change
On the last trading day, SLNO stock closed at 52.64 USD, with a price change of 0.02% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more